Immuneering (IMRX) Assets Average: 2021-2024
Historic Assets Average for Immuneering (IMRX) over the last 3 years, with Sep 2024 value amounting to $72.8 million.
- Immuneering's Assets Average fell 39.00% to $72.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $72.8 million, marking a year-over-year decrease of 39.00%. This contributed to the annual value of $112.5 million for FY2023, which is 22.18% down from last year.
- Latest data reveals that Immuneering reported Assets Average of $72.8 million as of Q3 2024, which was down 11.77% from $82.5 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Assets Average registered a high of $165.4 million during Q4 2021, and its lowest value of $72.8 million during Q3 2024.
- In the last 3 years, Immuneering's Assets Average had a median value of $116.3 million in 2023 and averaged $116.6 million.
- Its Assets Average has fluctuated over the past 5 years, first rose by 27.02% in 2022, then crashed by 39.00% in 2024.
- Over the past 4 years, Immuneering's Assets Average (Quarterly) stood at $165.4 million in 2021, then decreased by 22.58% to $128.0 million in 2022, then dropped by 15.46% to $108.2 million in 2023, then tumbled by 39.00% to $72.8 million in 2024.
- Its Assets Average stands at $72.8 million for Q3 2024, versus $82.5 million for Q2 2024 and $95.3 million for Q1 2024.